GlobeNewsWire
10 Jun 2026, 11:47 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Polyrizon's patent application for its Trap & Target (T&T) mucoadhesive polymer technology has been published by the European Patent Office. — Expanding intellectual property protection in Europe increases the company's valuation and attractiveness for future pharmaceutical partnerships.
+0.30The Trap & Target technology is currently in the early stage of pre-clinical development. — The early stage of development indicates that commercialization and revenue generation from this specific platform are still far off.
-0.10The European patent application must still undergo the formal examination process before being granted. — Publication is a procedural step, not a guarantee of a granted patent, leaving open the risk of rejection or narrow claims.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reached a significant milestone with the European patent publication for its proprietary nasal drug delivery technology.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
Seeking Alpha
8h ago
